Newer methods of labeling diagnostic agents with Tc-99m

Seminars in Nuclear Medicine

Volumn 31, Issue 4, 2001, Pages 278-285

  Mease, Ronnie C ^a   Lambert, Carol ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; CHELATE; HYDRAZINONICOTINAMIDE; PEPTIDE; RADIOPHARMACEUTICAL AGENT; RHENIUM; STEROID; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; DRUG PURIFICATION; DRUG STRUCTURE; ISOTOPE LABELING; OXIDATION; RADIOCHEMISTRY; SOLID STATE;

EID: 0034753262     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/snuc.2001.26182     Document Type: Article

References (61)

1. Technetium radiopharmaceuticals: Fundamentals, synthesis, structure, and development
2. Potential technetium small molecule radiopharmaceuticals
3. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging results
4. 99mTc labeling of highly potent small peptides
5. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals
6. 99mTc
7. Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium
8. Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies
9. Lipophilic Tc complexes. VI. Neutral oxotechnetium(V) complexes with monothiol/tridentate coordination
10. Stability versus reactivity of "3+1" mixed-ligand technetium-99m complexes in vitro and in vivo
11. TROTEC-1: A new high-affinity ligand for labeling of the dopamine transporter
12. Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: Structure-affinity considerations
13. Structural modification of receptor-binding technetium-99m complexes in order to improve brain uptake
14. Radiochemical synthesis and tissue distribution of Tc-99m-labeled 7alpha-substituted estradiol complexes
15. Synthesis and binding affinities of novel Re-containing 7a-substituted estradiol complexes: Models for breast cancer imaging agents
16. Synthesis and binding affinities of new 17 alpha-substituted estradiol-rhenium "n + 1" mixed-ligand and thioether-carbonyl complexes
17. Synthesis of novel progestin-rhenium conjugates as potential ligands for the progesterone receptor
18. 99mTc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein
19. - in aqueous solution and its reaction with a bifunctional ligand
20. 99mTc
21. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: A hint for the future functionalization of biomolecules
22. +-core
23. 3 moieties to biologically active molecules
24. 99mTc(I)-carbonyl labeled octreotate conjugates
25. 2
26. The functional expression of antibody Fv fragments in Escherichia coli: Improved vectors and a generally applicable purification technique
27. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex
28. Boronic acids in the three-component synthesis of carbon-substituted cyclopentadienyl tricarbonyl rhenium complexes
29. A convenient three-component synthesis of substituted cyclopentadienyl tricarbonyl rhenium complexes
30. Three-component synthesis of substituted h5-cyclopentadienyl tricarbonylrhenium complexes: Scope, limitations, and mechanistic interpretations
31. Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricar-bonyltechnetium-labeled octreotide
32. Preparation of cyclopentadienyl tricarbonylrhenium complexes using a double ligand transfer reaction
33. Protein and peptide labeling with (cyclopentadienyl)tricarbonyl rhenium and technetium
34. Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones
35. Selective formation of heterodimeric bis-bidentate aminothiol oxometal complexes of rhenium(V)
36. Heterodimeric bis(amino thiol) complexes of oxorhenium(V) that mimic the structure of steroid hormones. Synthesis and stereochemical issues
37. Synthesis of a tetradentate oxorhenium(V) complex mimic of a steroidal estrogen
38. 99mTc-labeled peptides
39. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats
40. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands
41. New and versatile ternary ligand system for technetium radiopharmaceuticals: Water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc
42. 99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide
43. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands
44. RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging
45. 99m-Technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicity and stability on biodistribution
46. 99mTc-labeled radiopharmaceuticals
47. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent
48. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma
49. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods
50. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadi-poylglycylglycine (N3S-adipate)
51. 99mTc]chelator-peptide conjugates
52. 99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent
53. High-affinity no-carrier-added 99mTc-labeled chemotactic peptides for studies of inflammation in vivo
54. Validation and application of a solid phase chemistry method for preparation of high effective specific-activity technetium-99m radiopharmaceuticals
55. Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology
56. A convenient method of preparing high specific-activity technetium complexes using thiol-containing chelators adsorbed on gold
57. 94mTc for positron emission tomography studies
58. Technetium 94m-labeled methoxyisobutyl isonitrile: Dosimetry and resting cardiac imaging with positron emission tomography
59. Technetium-94m-teboroxime: Synthesis, dosimetry and initial PET imaging studies
60. 99mTc]trodat-I as imaging agents for the dopamine transporter
61. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m